medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2012, Number 09

<< Back Next >>

Ginecol Obstet Mex 2012; 80 (09)

Review by expert group in the diagnosis and treatment of anemia in pregnant women

Montoya RJJ, Castelazo ME, Valerio CE, Velázquez CG, Nava MDA, Escárcega PJA, Montoya CJ, Pichardo VGM, Maldonado AA, Santana GHR, Fajardo DS, Mondragón GCG, García LT, García A, Hernández MM, Chávez GLE, Jiménez GC

Language: Spanish
References: 44
Page: 563-580
PDF size: 1146.57 Kb.


ABSTRACT

Background: According to data from the World Health Organization and UNICEF from year 2009, iron deficiency is the most widespread nutritional deficiency worldwide. This deficiency causes an imbalance between needs and iron supply, which consequently results in anemia. Around the world, two million people suffer from anemia, half of which is due to iron deficiency. The most impacted groups are children and teenagers, due to their highest requirements derived from the growing process, and women in their reproductive age, due to their loss of iron derived from menstruating or to their highest iron needs during pregnancy. This increase in needs is not satisfied by the regular diet, since it includes an insufficient amount and/or low bioavailability of iron.
Purpose: To share with the medical community treating pregnant women the experience of an expert group so that they always bear in mind the repercussions caused by anemia during pregnancy, know more about the diagnostic possibilities and have a reference point for prescribing iron supplements.
Method: The consensus method was used through the expert panel group technique. Two rounds were taken for structuring the clinical questions. The first one was to facilitate working groups their focusing in the clinical topics and the population of interest; the second one was to aid in posing specific questions observing the Patient, Intervention, Compare and Outcome (PICO) structure. The primary and clinical secondary study variables were defined by the working groups from the previously developed questions and during the face-toface working period, according to the natural history of the disease: risk factors, diagnostic classification, (either pharmacological or non pharmacological) treatment and prognosis. The level of evidence and clinical recommendation was classified based on the Evidence Classification Level and Clinical Recommendation of the Medicine Group based on Evidence from Oxford University.
Results: In Mexico, 20.6% of pregnant women suffer from anemia, especially those between 15 and 16 years old, who prevail in 42.4% and 34.3% percent, respectively. Almost half the cases are due to iron deficiency. This type of anemia is associated with a higher risk of pre-term delivery, of low birth weight and perinatal death. The first assessment of an anemic pregnant woman shall include the medical history, a physical examination and the quantification of the erythrocyte indices, serum concentrations of iron and ferritin. The measurement of this last one has the highest sensitivity and specificity for diagnosing iron deficiency. Daily oral iron supplementation, at a 60-to-120 mg dosage, may correct most of mild-to-moderate anemias. The most appropriate treatment is with iron salts (iron sulfate, polimaltose iron complex or iron fumarate). In case of intolerance to iron sulfate or fumarate, polimaltose iron is a better tolerated option. Treatment shall be administered until the hemoglobin values are › 10.5 g and ferritin is between 300 and 360 µg/dL, and such levels shall be observed for at least one year. Parenteral administration is an alternative for patients with a severe intolerance to oral administration; even when the possibility of anaphylaxis shall be considered it is lower when using ferrous sacarate. Transfusion is reserved for patients with hemoglobin lower than 7 g/dL or having an imminent cardio-respiratory decompensation.
Conclusions: Iron deficiency is the highest prevailing nutritional deficiency worldwide and its consequences during pregnancy may be highly risky for both the mother and her child. Anemia diagnosis may easily be achieved through a blood analysis including the serum ferritin determination. Serum iron measurement shall not be used as the only marker to set the diagnosis. It is important to rule out other causes, in addition to the deficiencies, which produce anemia in a patient. It is essential to suggest the administration of iron supplements not only during the antenatal period but also after birth o even after a miscarriage to fulfill the need for depleted iron. In severe anemias (hemoglobin being lower than 9.0 g/L), iron doses higher than 120 mg a day may be required. Treatment shall always begin orally, and if this is not well tolerated, parenteral administration shall be used.


REFERENCES

  1. Olivares M, Walter T, Hertrampf E, et al. Anaemia and iron deficiency disease in children. Br Med Bull 1999; 55:534-548.

  2. de Benoist B, McLean E, Egli I, et al. Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia. WHO Library Cataloguing-in-Publication Data. 2008. Available from: www.who.int/vmnis/publications/anaemia_prevalence/ en/index.html [Accessed 3 December 2010].

  3. Amy L Frith-Terhune, Mary E Cogswell, Laura Kettel Khan,et al. Iron deficiency anemia: higher prevalence in Mexican American than in non-Hispanic white females in the third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr 2000;72:963–968.

  4. Secretaría de Salud. Encuesta Nacional de Nutrición 1988. Dirección General de Epidemiología, México, 1988.

  5. Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, et al. Encuesta Nacional de Nutrición 1999. Estado nutricio de niños y mujeres en México. Instituto Nacional de Salud Pública, 2001.

  6. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, et al. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública, 2006.

  7. Bob Phillips, Chris Ball, Dave Sackett, et al since November 1998. Updated by Jeremy Howick March 2009. Oxford Centre for Evidence-based Medicine Levels of Evidence. www.cebm. net/index.aspx?o=1025

  8. Iron deficiency anaemia. Assessment, prevention, and control. Guide for programme manager. WHO/UNU/UNICEF.2001

  9. ACOG Practice Bulletin Anemia in Pregnancy. Obstetrics & Gynecology 2008;112(1):201-207.

  10. Sangvhi T, Harvey P, Wainwright E. Maternal iron-folate acid supplementation on programs: evidence of impact and implementation. Food and Nutrition Bulletin 2010:31(2):S100-S107.

  11. Girard A. Maternal undernutrition: evidence, links and solutions. Presentation to the Woodrow Wilson International Center for Scholars, 15 December 2010, Washington, DC.

  12. Recommendations to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998;47(RR-3):1–29.

  13. World Health Organization. Indicators and strategies for iron deficiency and anemia programmes. Report of the WHO/ UNICEF/UNU consultation. Geneva, Switzerland, 610 December, 1993

  14. Moreno Chulilla JA, Romero Colás MS, Gutiérrez Martín M. Classification of anemia for gastroenterologists. World J Gastroenterol 2009;15(37):4627-4637

  15. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Developing clinical guidelines. BMJ 1999;318:593-6.:

  16. Guidelines and Protocols Advisory Committee. Approved by British Columbia Medical Association, 2004

  17. Guía de Práctica Clínica. Diagnóstico y Tratamiento de la anemia por deficiencia de hierro en niños y adultos. México: Secretaría de Salud 2010.

  18. Comité Nacional de Hematología Sociedad Argentina de Pediatría, 2009

  19. Berti C, Biesalske HK, Gartner R, et al. Micronutrients in pregnancy: Current knowledge and unresolved questions. Clinical Nutrition 2011;30:689-701

  20. Bothwell TH, Charlton RW. Iron deficiency in women. Washington, DC: The Nutrition Foundation;1981

  21. Baynes RD. Iron deficiency. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, editors. Iron metabolism in health and disease. Philadelphia (PA): W.B. Saunders;1994. p.189–225

  22. Ontario Association of Medical Laboratories. Guidelines or the use of serum tests for iron deficiency. Guidelines for Clinical Laboratory Practice CLP 002. North York(ON): OAML; 1995. Available at: http://www.oaml.com/PDF/CLP002.pdf. Retrieved April 4, 2008.

  23. Agency for Healthcare Research and Quality. Screening for iron deficiency anemia in childhood and pregnancy: update of the 1996 U.S. Preventive Task Force review. AHRQ Publication No. 06-0590-EF-1. Rockville (MD): AHRQ; 2006.

  24. Ragip A. Al, Unlubilgin E, Kandemir O, et al. Intravenous Versus Oral Iron for Treatment of Anemia in Pregnancy: A Randomized Trial. Obstetrics & Gynecology 2005; 106(6): 1335-1340.

  25. Pasricha, S-R. S., Flecknoe-Brown, S.C., Allen, KJ, et al. Diagnosis and management of iron deficiency anaemia: a clinical update. MJA 2010;193:525–532

  26. Rasmussen K. Is there a causal relationship between iron deficiency or iron-deficiency anemia and weight at birth, length of gestation and perinatal mortality? J Nutr 2001;131:590S,601S; discussion 601S–603S.

  27. Crosby WH. The rationale for treating iron deficiency anemia. Arch Intern Med. 1984;144(3):471.

  28. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical research Council vitamin study. Lancet 1991;338:131-137.

  29. Feinleib, M., Beresford, SAA., Bowman, BA., Mills, JL., Rader, JI., Selhub, J., and Yetley, EA. Folate Fortification for the Prevention of Birth Defects: Case Study. Am J Epidemiol 2001; 154(12): S60-S69.

  30. David Zieve, MD, MHA, David R. Eltz. Previously reviewed by David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine. Complete blood count (2/9/2010)

  31. Coada, J. and Conlonb, C. Iron deficiency in women: assessment, causes and consequences. Current Opinion in Clinical Nutrition and Metabolic Care 2011;14:625–634.

  32. Alleyne M, Horne MK, Miller JL. Individualized treatment for iron-deficiency anemia in adults. Am J Med 2008;121(11):943.

  33. Boggs DR. Fate of a ferrous sulfate prescription. Am J Med 1987;82(1):124.

  34. Goddard AF, James MW, McIntyre AS, et al. Gut gut. 2010.228874 Published Online First: 11 May 2011 doi:10.1136/ gut.2010.228874

  35. Faich G, Strobos J. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans. Am J Kidney Dis 1999;33:464–470.

  36. Yasa B, Agaoglu L, and Unuvar E. Efficacy, Tolerability, and Acceptability of Iron Hydroxide Polymaltose Complex versus Ferrous Sulfate: A Randomized Trial in Pediatric Patients with Iron Deficiency Anemia. International Journal of Pediatrics 2011;31:1-6

  37. Ortiz R, Toblli JE, Romero JD, et al. Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study. J Matern Fetal Neonatal Med 2011;24(11):1-6.

  38. Lee PL, Barton JC, Khaw PL, Bhattacharjee SY, Barton JC. Common TMPRSS6 mutations and iron, erythrocyte, and pica phenotypes in 48 women with iron deficiency or depletion. Blood Cells Mol Dis 2012;15(48):124-127

  39. Barton JC, Barton JC, Bertoli LF. Pica associated with iron deficiency or depletion: clinical and laboratory correlates in 262 non-pregnant adult outpatients. BMC Blood Disord 2010;22(10):9.

  40. Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG 2006;113:1248–1252.

  41. Goddard AF, Scott BB. Guidelines for the management of iron deficiency anaemia. Gut 2000:46(suppl 4):iv1-iv5

  42. Patra, S., Puri, M., et al. Clinical profile of women with severe anaemia in the third trimester of pregnancy. Tropical Doctor April 2010

  43. Saldías, P.F., Farías G.G., Villarroel, D.L., Valdivia, C.G., Mardónez, U.J.M., Díaz, F.A. Diseño de un índice pronóstico clínico para manejo de neumonía del adulto. Rev Med Chile 2004; 132(9): 1037-1046

  44. World Health Organization. The Prevalence of Anaemia in Women: A Tabulation of Available Information, 2nd ed. Geneva: WHO, 1992




2020     |     www.medigraphic.com